Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for Chronic Migraine
NCT06322407Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Change from baseline in mean monthly migraine days at 6 months. Started Jun 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06322407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06322407.